Halozyme Therapeutics Inc
HALO59.180USD
+0.160+0.27%
交易中 （美東）報價延遲15分鐘
7.29B總市值
15.02本益比TTM
關於 Halozyme Therapeutics Inc 公司
Halozyme Therapeutics, Inc. 是一家生物製藥公司，致力於開發顛覆性解決方案，以改善新興和成熟療法的患者體驗和療效。該公司的 ENHANZE 藥物輸送技術採用專有酶 rHuPH20，其經過商業驗證的解決方案用於促進注射藥物和液體的皮下 (SC) 輸送，重點是減輕患者的治療負擔。該公司還利用其先進的自動注射器技術爲自己或與合作伙伴開發、製造和商業化藥物-設備組合產品。該公司擁有兩種商業專有產品 Hylenex 和 XYOSTED，與多家制藥公司合作開發商業產品並正在進行產品開發計劃。該公司營銷和銷售 Hylenex 重組體，這是 rHuPH20 的一種配方。該公司營銷和銷售其專有產品 XYOSTED，用於成年男性的睾酮替代療法 (TRT) 的 SC 給藥。
公司簡介
公司代碼HALO
公司名稱Halozyme Therapeutics Inc
上市日期Jan 30, 2003
CEODr. Helen I. Torley
員工數量350
證券類型Ordinary Share
年結日Jan 30
公司地址12390 El Camino Real
城市SAN DIEGO
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編92130
電話18587948889
網址https://www.halozyme.com/
公司代碼HALO
上市日期Jan 30, 2003
CEODr. Helen I. Torley
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Helen I. Torley
Dr. Helen I. Torley
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
733.72K
--
Mr. Matthew L. (Matt) Posard
Mr. Matthew L. (Matt) Posard
Independent Director
Independent Director
74.04K
+5.96%
Ms. Nicole Labrosse
Ms. Nicole Labrosse
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
31.90K
--
Dr. Mahesh Krishnan, M.D.
Dr. Mahesh Krishnan, M.D.
Independent Director
Independent Director
--
--
Ms. Moni Miyashita
Ms. Moni Miyashita
Independent Director
Independent Director
--
--
Mr. Jeffrey W. (Jeff) Henderson
Mr. Jeffrey W. (Jeff) Henderson
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Mark Snyder
Mr. Mark Snyder
Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
--
--
Ms. Bernadette M. Connaughton
Ms. Bernadette M. Connaughton
Independent Director
Independent Director
--
--
Ms. Barbara Duncan
Ms. Barbara Duncan
Independent Director
Independent Director
--
--
Ms. Tram Bui
Ms. Tram Bui
Vice President - Investor Relations and Corporate Communications
Vice President - Investor Relations and Corporate Communications
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Helen I. Torley
Dr. Helen I. Torley
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
733.72K
--
Mr. Matthew L. (Matt) Posard
Mr. Matthew L. (Matt) Posard
Independent Director
Independent Director
74.04K
+5.96%
Ms. Nicole Labrosse
Ms. Nicole Labrosse
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
31.90K
--
Dr. Mahesh Krishnan, M.D.
Dr. Mahesh Krishnan, M.D.
Independent Director
Independent Director
--
--
Ms. Moni Miyashita
Ms. Moni Miyashita
Independent Director
Independent Director
--
--
Mr. Jeffrey W. (Jeff) Henderson
Mr. Jeffrey W. (Jeff) Henderson
Independent Chairman of the Board
Independent Chairman of the Board
--
--
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Royalties
168.19M
63.50%
Sales of proprietary products
36.34M
13.72%
Sales of bulk rHuPH20
27.02M
10.20%
Sales-based milestones
15.00M
5.66%
Sales of device partnered products
14.68M
5.54%
Other
3.63M
1.37%
暫無數據
業務
地區
業務USD
名稱
營收
佔比
Royalties
168.19M
63.50%
Sales of proprietary products
36.34M
13.72%
Sales of bulk rHuPH20
27.02M
10.20%
Sales-based milestones
15.00M
5.66%
Sales of device partnered products
14.68M
5.54%
Other
3.63M
1.37%
股東統計
更新時間: 7月29日 週二
更新時間: 7月29日 週二
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
12.16%
The Vanguard Group, Inc.
10.39%
State Street Global Advisors (US)
4.91%
Snyder Capital Management, L.P.
2.98%
AllianceBernstein L.P.
2.61%
Other
66.94%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
12.16%
The Vanguard Group, Inc.
10.39%
State Street Global Advisors (US)
4.91%
Snyder Capital Management, L.P.
2.98%
AllianceBernstein L.P.
2.61%
Other
66.94%
股東類型
持股股東
佔比
Investment Advisor
58.36%
Investment Advisor/Hedge Fund
30.60%
Research Firm
4.57%
Pension Fund
2.37%
Hedge Fund
1.88%
Bank and Trust
1.48%
Sovereign Wealth Fund
1.16%
Individual Investor
1.11%
Insurance Company
0.12%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
1032
125.13M
101.55%
-10.49M
2025Q1
1043
127.91M
103.79%
-10.64M
2024Q4
999
127.73M
103.64%
-14.45M
2024Q3
953
129.39M
102.16%
-10.33M
2024Q2
905
126.24M
99.18%
-14.91M
2024Q1
870
127.71M
100.45%
-13.70M
2023Q4
850
128.82M
97.51%
-11.71M
2023Q3
836
127.73M
96.80%
-13.97M
2023Q2
838
128.24M
97.33%
-12.36M
2023Q1
833
129.53M
95.63%
-10.61M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
14.99M
12.16%
-268.69K
-1.76%
Mar 31, 2025
The Vanguard Group, Inc.
12.80M
10.39%
-451.45K
-3.41%
Mar 31, 2025
State Street Global Advisors (US)
6.05M
4.91%
-1.13M
-15.75%
Mar 31, 2025
Snyder Capital Management, L.P.
3.67M
2.98%
-494.15K
-11.85%
Mar 31, 2025
AllianceBernstein L.P.
3.22M
2.61%
+146.68K
+4.78%
Mar 31, 2025
Geode Capital Management, L.L.C.
3.17M
2.57%
+105.17K
+3.43%
Mar 31, 2025
Macquarie Investment Management
2.67M
2.17%
-231.21K
-7.96%
Mar 31, 2025
Invesco Capital Management LLC
2.42M
1.96%
+628.59K
+35.15%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
2.03M
1.65%
+95.60K
+4.94%
Mar 31, 2025
Congress Asset Management Company, LLP
2.13M
1.73%
+172.97K
+8.83%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Future Fund Long/Short ETF
3.76%
First Trust NYSE Arca Biotechnology Index Fund
2.71%
Invesco Biotechnology & Genome ETF
2.54%
SPDR S&P Biotech ETF
2.35%
Congress SMid Growth ETF
2.21%
Janus Henderson Small Cap Growth Alpha ETF
2.05%
Invesco S&P MidCap 400 GARP ETF
1.92%
Janus Henderson Small/Mid Cap Growth Alpha ETF
1.92%
Virtus LifeSci Biotech Products ETF
1.84%
Alpha Architect US Quantitative Value ETF
1.84%
查看更多
Future Fund Long/Short ETF
佔比3.76%
First Trust NYSE Arca Biotechnology Index Fund
佔比2.71%
Invesco Biotechnology & Genome ETF
佔比2.54%
SPDR S&P Biotech ETF
佔比2.35%
Congress SMid Growth ETF
佔比2.21%
Janus Henderson Small Cap Growth Alpha ETF
佔比2.05%
Invesco S&P MidCap 400 GARP ETF
佔比1.92%
Janus Henderson Small/Mid Cap Growth Alpha ETF
佔比1.92%
Virtus LifeSci Biotech Products ETF
佔比1.84%
Alpha Architect US Quantitative Value ETF
佔比1.84%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
